With Tuft’s research showcasing the 5x and 13x return on Phase II and III trials, many in the industry are keen to learn more about decentralized clinical trials.
Learn how to accelerate and scale your trials using decentralized and hybrid trial best practices in this webinar from Medable and ACT.
Jared Klingeisen is Senior Vice President of Partner DCT Enablement Strategy.
